The US Food and Drug Administration (FDA) has granted approval for Lupin’s perindopril erbumine tablets, 2mg, 4mg and 8mg for the treatment of patients with essential hypertension.

Perindopril erbumine tablets are AB-rated to Aceon tablets indicated for the treatment of patients with essential hypertension and can be used with conventional treatment for the management of coronary artery disease.

Aceon had annual sales of approximately $24m for the 12 months ended September 2009, based on IMS Health sales data.

Commercial shipments of the product will begin shortly.